Recent news on Foscarnet

Zalcitabine Syrup (Zalcitabine capsule) Information  -  May 17, 2007
American Chronicle,Aminoglycosides, amphotericin, foscarnet: May increase risk of peripheral neuropathy and other zalcitabine toxicities caused by decreased clearance of

ADVENTRX Awards Manufacturing Contract for ANX-201 (Thiovir(TM))  -  Mar 28, 2007
Drug Newswire (press release),The HIV resistance profile of ANX-201 and foscarnet is unique among RTIs reflecting the distinct mechanism of action of this novel drug class.

Contract manufacturing news in brief  -  Apr 3, 2007
In-PharmaTechnologist.com,According to Adventrix, the HIV resistance profile of ANX-201 and foscarnet is unique among RTIs due to the distinct mechanism of action of this novel drug

ADVENTRX To Present Thiovir Preclinical Data At The 20th ...  -  Feb 13, 2007
Medical News Today (press release),Thiovir is an analogue of foscarnet that delivers both the active drug TPFA (thiophosphonoformate) and the active metabolite PFA (foscarnet) in an oral

Research Paves Way Toward Less Toxic HIV Drugs  -  Feb 8, 2007
Science Daily (press release)Science Daily — McGill University researchers have discovered how the antiviral agent foscarnet inhibits HIV replication, laying the groundwork for the

Options for treating ganciclovir-resistant CMV discussed at IDSA ...  Oct 16, 2006
The current options are the intravenous drugs ganciclovir (Cymevene), foscarnet (Foscavir) and cidofovir (Vistide), and the oral valganciclovir (Valcyte. ... -Aidsmap, Refractory cytomegalovirus infection successfully treated after ...  Aug 15, 2006
2006 AUG 15 - (NewsRx.com) -- Foscarnet plus leflunomide successfully treats refractory cytomegalovirus infection following stem cell transplantation. ... -Therapeutics Daily (subscription)

ADVENTRX Presents Broad Antiviral Activity for Thiovir  Jun 22, 2006
Thiovir is a prodrug for foscarnet that delivers both the active drug TPFA (thiophosphonoformate) and the active metabolite PFA (foscarnet). ... -Yahoo! News



Hospira Reports First-Quarter 2006 Results  May 9, 2006
Launched the anti-infective foscarnet, the first of Hospira's generic injectable pharmaceutical product launches planned for 2006. ... - MSN Money

ADVENTRX to Present Positive Thiovir Antiviral Activity Results  Apr 26, 2006
Thiovir is a prodrug for foscarnet that delivers both the active drug TPFA (thiophosphonoformate) and the active metabolite PFA (foscarnet). ... - Yahoo! News





ADVENTRX Presents Positive Thiovir Preclinical Results  Apr 3, 2006
Thiovir is a broad spectrum antiviral and oral prodrug for foscarnet, a drug approved to treat opportunistic infections in HIV/AIDS patients. ... - Yahoo! News

ADVENTRX Pharma Says Preclinical Studies Of Thiovir-zidovudine ...  Apr 3, 2006
Thiovir is a broad spectrum antiviral and oral prodrug for foscarnet, a drug approved to treat opportunistic infections in HIV/AIDS patients. ... - Trading Markets

ADVENTRX Announces Upcoming Scientific Conference Presentations  Mar 28, 2006
Thiovir is a prodrug for foscarnet that delivers both the active drug TPFA (thiophosphonoformate) and the active metabolite PFA (foscarnet) in an oral ... - Yahoo! News

ADVENTRX Pharma Says Thiovir-zidovudine Combination Pre-clinical ...  Apr 3, 2006
The antiviral synergy between Thiovir and zidovudine was significantly more pronounced than antiviral activity of combinations of foscarnet and zidovudine ... - Trading Markets

Adventrx antiviral shows promise against bird flu  Mar 21, 2006
Thiovir is intended to deliver the benefits of the antiviral drug foscarnet, including broad spectrum antiviral activity, with the added benefit of improved ... - Pharmaceutical Business Review

Proteins can help cells protect themselves from infection with HIV  Mar 13, 2006
...newly-infected cells to the drugs from the non-nucleoside inhibitor class – the anti-HIV drug efavirenz (Sustiva) and the drug foscarnet, which although ... - Aidsmap

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional